{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:44:38Z","timestamp":1792154678573,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","meddos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Dosimetry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.meddos.2026.09.002","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:58Z","timestamp":1790121658000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["LINAC-based online adaptive stereotactic ablative radiotherapy for kidney tumors: In silico analysis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7532-5926","authenticated-orcid":false,"given":"Olivia G.","family":"Moncrief","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Grace","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel Z.","family":"Larramendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiachien J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsinshun T.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip F.","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylee A.","family":"Kallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3758-9093","authenticated-orcid":false,"given":"Yohan A.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.meddos.2026.09.002_bib0001","doi-asserted-by":"crossref","DOI":"10.14740\/wjon1279","article-title":"Epidemiology of renal cell carcinoma","volume":"11","author":"Padala","year":"2020","journal-title":"World J. Oncol."},{"issue":"1","key":"10.1016\/j.meddos.2026.09.002_bib0002","article-title":"NCCN guidelines\u00ae insights: Kidney cancer, version 2.2024","volume":"22","author":"Motzer","year":"2024","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"4","key":"10.1016\/j.meddos.2026.09.002_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/cancers3044010","article-title":"Role of radiation therapy in the management of renal cell cancer","volume":"3","author":"Blanco","year":"2011","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.meddos.2026.09.002_bib0004","doi-asserted-by":"crossref","DOI":"10.1038\/nrurol.2017.87","article-title":"Radiotherapy for renal cell carcinoma: Renaissance of an overlooked approach","volume":"14","author":"Siva","year":"2017","journal-title":"Nat. Rev. Urol."},{"issue":"3","key":"10.1016\/j.meddos.2026.09.002_bib0005","doi-asserted-by":"crossref","DOI":"10.22465\/juo.234600560028","article-title":"Role of radiotherapy in metastatic renal cell carcinomas: An evolutionary journey in a misunderstood histological type","volume":"21","author":"Wee","year":"2023","journal-title":"J. Urol. Oncol."},{"issue":"11 B","key":"10.1016\/j.meddos.2026.09.002_bib0006","article-title":"A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma","volume":"110","author":"Siva","year":"2012","journal-title":"BJU Int."},{"issue":"5","key":"10.1016\/j.meddos.2026.09.002_bib0007","article-title":"Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): A meta-analysis of 28 studies","volume":"2","author":"Zaorsky","year":"2019","journal-title":"Eur. Urol. Oncol."},{"issue":"5","key":"10.1016\/j.meddos.2026.09.002_bib0008","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.31156","article-title":"Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK)","volume":"124","author":"Siva","year":"2018","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.meddos.2026.09.002_bib0009","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000000111","article-title":"Stereotactic radiotherapy as a treatment option for renal tumors in the solitary kidney: A multicenter analysis from the IROCK","volume":"201","author":"Correa","year":"2019","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.meddos.2026.09.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2016.06.240","article-title":"Principal analysis of a phase ib trial of stereotactic body radiation therapy (SBRT) for primary kidney cancer","volume":"96","author":"Siva","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"12","key":"10.1016\/j.meddos.2026.09.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(22)00656-8","article-title":"5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: An individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the kidney)","volume":"23","author":"Siva","year":"2022","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.meddos.2026.09.002_bib0012","article-title":"Long-term renal function outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma including patients with a solitary kidney: A report from the International Radiosurgery Oncology Consortium of the Kidney","volume":"7","author":"Tan","year":"2024","journal-title":"Eur. Urol. Oncol."},{"issue":"3","key":"10.1016\/j.meddos.2026.09.002_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(24)00020-2","article-title":"Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): A non-randomised phase 2 trial","volume":"25","author":"Siva","year":"2024","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.meddos.2026.09.002_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2017.01.032","article-title":"Safety and efficacy of stereotactic ablative radiation therapy for renal cell carcinoma extracranial metastases","volume":"98","author":"Wang","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.meddos.2026.09.002_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(23)00513-2","article-title":"Stereotactic body radiotherapy for primary renal cell carcinoma: A systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS)","volume":"25","author":"Siva","year":"2024","journal-title":"Lancet Oncol."},{"issue":"21","key":"10.1016\/j.meddos.2026.09.002_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15215272","article-title":"Online adaptive MRI-guided stereotactic body radiotherapy for pancreatic and other intra-abdominal cancers","volume":"15","author":"Lee","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.meddos.2026.09.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2019.01.020","article-title":"Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk","volume":"134","author":"Loi","year":"2019","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.meddos.2026.09.002_bib0018","article-title":"Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer","volume":"39","author":"Uchinami","year":"2023","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.meddos.2026.09.002_bib0019","article-title":"Dosimetric impact of daily skin surface variations in kidney stereotactic ablative proton therapy","volume":"39","author":"Walter","year":"2026","journal-title":"Tech. Innov. Patient. Support. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.meddos.2026.09.002_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-80626-5","article-title":"Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients","volume":"14","author":"Jiang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.meddos.2026.09.002_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.634830","article-title":"Adaptive magnetic resonance-guided stereotactic body radiotherapy: The next step in the treatment of renal cell carcinoma","volume":"11","author":"Keller","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.meddos.2026.09.002_bib0022","article-title":"Stereotactic magnetic resonance-guided adaptive radiation therapy for localized kidney cancer: Early outcomes from a prospective phase 1 trial and supplemental cohort","volume":"7","author":"Yim","year":"2024","journal-title":"Eur. Urol. Oncol."},{"issue":"1","key":"10.1016\/j.meddos.2026.09.002_bib0023","doi-asserted-by":"crossref","DOI":"10.3857\/roj.2024.00521","article-title":"Planning evaluation of stereotactic magnetic resonance\u2013guided online adaptive radiosurgery for kidney tumors close to the organ at risk: Is it valuable to wait for good timing to perform stereotactic radiosurgery?","volume":"43","author":"Yamamoto","year":"2025","journal-title":"Radiat. Oncol. J."},{"issue":"1","key":"10.1016\/j.meddos.2026.09.002_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2021.09.027","article-title":"A story of hypofractionation and the table on the wall","volume":"112","author":"Timmerman","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.meddos.2026.09.002_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/S0360-3016(00)00518-6","article-title":"The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy","volume":"47","author":"Van Herk","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.meddos.2026.09.002_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2024.04.066","article-title":"Dose-effect relationship of kidney function after SABR for primary renal cell carcinoma: TROG 15.03 FASTRACK II","volume":"120","author":"Gaudreault","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.meddos.2026.09.002_bib0027","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-8-248","article-title":"An analysis of respiratory induced kidney motion on four-dimensional computed tomography and its implications for stereotactic kidney radiotherapy","volume":"8","author":"Siva","year":"2013","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.meddos.2026.09.002_bib0028","unstructured":"RaySearch Laboratories. Synthetic CT generation in raystation for enhanced workflows in adaptive radiotherapy (Whitepaper). 2023. https:\/\/www.raysearchlabs.com\/49c5c9\/siteassets\/media\/publications\/white-papers\/wp-pdfs\/synthetic_ct_whitepaper.pdf."},{"issue":"11","key":"10.1016\/j.meddos.2026.09.002_bib0029","article-title":"Use of virtual CT and on-treatment MRI to reduce radiation dose and anesthesia exposure associated with the adaptive workflow in pediatric patients treated with intensity modulated proton therapy","volume":"9","author":"Sheikh","year":"2024","journal-title":"Adv. Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.meddos.2026.09.002_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/mp.16941","article-title":"Generation and evaluation of anatomy-preserving virtual CT for online adaptive proton therapy","volume":"51","author":"Kaushik","year":"2024","journal-title":"Med. Phys."},{"issue":"4","key":"10.1016\/j.meddos.2026.09.002_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.14577","article-title":"Efficacy of a thermoplastic mask and pneumatic abdominal compression device for immobilization in stereotactic ablative radiotherapy of spine metastases","volume":"26","author":"Walter","year":"2025","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"10.1016\/j.meddos.2026.09.002_bib0032","article-title":"Patient positional uncertainty and margin reduction in lung stereotactic ablative radiation therapy using pneumatic abdominal compression","author":"Walter","year":"2024","journal-title":"Pract. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.meddos.2026.09.002_bib0033","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1186\/s12885-025-14486-1","article-title":"Prospective phase II study of stereotactic body proton therapy for treatment of primary renal cell carcinoma (SPARE): Clinical trial protocol","volume":"25","author":"Shaaban","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.meddos.2026.09.002_bib0034","article-title":"In Silico comparison of photon versus proton based stereotactic body radiotherapy with increasing maximum peak dose for treatment of primary renal cell carcinoma","volume":"18","author":"Shaaban","year":"2025","journal-title":"Int. J. Part Ther."},{"key":"10.1016\/j.meddos.2026.09.002_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2026.03.016","article-title":"A ten-year patterns of use analysis for the world\u2019s first commercial compact pencil beam scanning proton therapy system","author":"Walter","year":"2026","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Medical Dosimetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394726000701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394726000701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:48:19Z","timestamp":1792151299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958394726000701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S0958394726000701"],"URL":"https:\/\/doi.org\/10.1016\/j.meddos.2026.09.002","relation":{},"ISSN":["0958-3947"],"issn-type":[{"value":"0958-3947","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LINAC-based online adaptive stereotactic ablative radiotherapy for kidney tumors: In silico analysis","name":"articletitle","label":"Article Title"},{"value":"Medical Dosimetry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meddos.2026.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Association of Medical Dosimetrists.","name":"copyright","label":"Copyright"}]}}